Children with severe malaria often present with lactic acidosis and hypogly
cemia. Although both complications independently predict mortality, mechani
sms underlying their development are poorly understood. To study these meta
bolic derangements we sequentially allocated 21 children with falciparum ma
laria and capillary lactate concentrations of 5 mmol/L or more to receive e
ither quinine or artesunate as antimalarial therapy, and dichloroacetate or
saline placebo for lactic acidosis. We then administered a primed infusion
(90 min) of L-[3-C-13(1)]sodium lactate and D-[6,6-D-2]glucose to determin
e the kinetics of these substrates. The mean (SD) glucose disposal rate in
all patients was 56 (16) mu mol/kg.min, and the geometric mean (range) lact
ate disposal rate was 100 (66-177) mu mol/kg.min. Glucose and lactate dispo
sal rates were positively correlated (r = 0.62; P = 0.005). Artesunate was
associated with faster parasite clearance, lower insulin/glucose ratios, an
d higher glucose disposal rates than quinine. Lactate disposal was positive
ly correlated with plasma lactate concentrations (r = 0.66; P = 0.002) and
time to recovery from coma (r = 0.82; P < 0.001; n = 15). Basal lactate dis
posal rates increased with dichloroacetate treatment. Elevated glucose turn
over in severe malaria mainly results from enhanced anaerobic glycolysis. Q
uinine differs from artesunate in its effects on glucose kinetics. Increase
d lactate production is the most important determinant of lactic acidosis.